On the recordOctober 10, 2017
We must ensure there is accountability and transparency in the program.
Source
congress.govEditor's note · Context
Griffith calls for accountability and transparency in the 340B drug pricing program.
Share & report
More from Howard Griffith
Apr 30, 2025
Mr. Speaker, I ask unanimous consent that when the House adjourns today, it adjourn to meet at 9 a.m. tomorrow. The SPEAKER pro tempore. Is there objection to the request of the gentleman from Virginia? There was no objection…
Apr 30, 2025
Madam Speaker, may I inquire as to the time remaining. The SPEAKER pro tempore (Ms. Foxx). The gentleman from Virginia has 5\1/2\ minutes remaining. The gentleman from New Jersey has 6 minutes remaining.
Apr 30, 2025
Mr. Speaker, referencing my previous comments related to the GAO, et cetera, I will not yield to the GAO on what the responsibilities of the United States Congress are. Mr. Speaker, I yield 4 minutes to the gentleman from California (Mr…
Apr 30, 2025
Mr. Speaker, pursuant to House Resolution 354, I call up the joint resolution (H.J. Res. 88) providing congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Environmental Protection Agency…
Other voices in this conversation
